Abstract:Objective: To investigate the clinical value of multiparameteric quantitative ultrasound combined with a non-invasive prediction model for assessing high-risk steatohepatitis. Methods: One hundred and ninety-four cases with metabolic-associated fatty liver disease (MAFLD) who underwent liver biopsy in Huashan Hospital, Fudan University, from June 2021 to September 2022 were selected. Shear wave elastography (SWE), shear wave dispersion (SWD) imaging, and attenuation imaging (ATI) examinations were conducted in all patients before biopsy. High-risk steatohepatitis was defined as a total activity score of ≥4 in patients with steatohepatitis, hepatocellular ballooning, and liver lobular inflammation based on pathological hepatic steatosis, inflammatory activity, and fibrosis scoring system (SAF), and fibrosis stage≥F2. Binary logistic regression analysis was used to identify the factors influencing high-risk steatohepatitis. A predictive model for diagnosing high-risk steatohepatitis was constructed using R language. The DeLong test was used to compare the area under the curve between groups. Measurement data was compared between groups using the t-test or rank-sum test, and count data were compared between groups using the χ2 test. Results: There were 46 cases (23.7%) with high-risk steatohepatitis. The quantitative ultrasound parameters included elastic modulus (OR=2.958, 95%CI: 1.889-4.883, P<0.001), dispersion coefficient (OR=1.786, 95%CI: 1.424-2.292, P<0.001) and attenuation coefficient (OR=42.642, 95%CI: 3.463-640.451, P=0.004). Serological indexes of fasting blood glucose (OR=1.196, 95%CI: 1.048-1.392, P=0.011), alanine aminotransferase (OR=1.012, 95%CI: 1.006-1.019, P<0.001), aspartate aminotransferase (OR=1.027, 95%CI: 1.014-1.042, P<0.001), γ-glutamyl transferase (OR=1.008, 95%CI: 1.001-1.017, P=0.041) and HDL cholesterol (OR=0.087, 95%CI: 0.016-0.404, P=0.003) were the factors influencing its progression. The AUCs of elastic modulus, dispersion coefficient, attenuation coefficient, multiparametric ultrasound model, serological index model, and ultrasound combined with serology model for the diagnosis of high-risk steatohepatitis were 0.764, 0.758, 0.634, 0.786, 0.773 and 0.825, respectively. The results of the DeLong test showed that the ultrasound combined with the serological model was significantly better than the serological index model and the elastic modulus, dispersion coefficient, and attenuation coefficient alone (P=0.024, 0.027, 0.038 and <0.001). Conclusion: The combination of multiparametric quantitative ultrasound is helpful for the non-invasive diagnosis of high-risk steatohepatitis and possesses great clinical significance.

Could Semiquantitative Analysis of Real-Time Ultrasound Elastography Distinguish More Liver Parenchyma Alterations of Nonalcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome?

Study on the Relationship Between Different Patterns of Nonalcoholic Fatty Liver Disease and the Levels of TNF-α and IL-6

Non-alcoholic Fatty Liver Disease: an Early Mediator Predicting Metabolic Syndrome in Obese Children?

Hepatic steatosis in women with polycystic ovary syndrome

Analysis of Related Factors for Polycystic Ovary Syndrome Patients Complicated Non-Alcoholic Fatty Liver Disease

Tissue fat quantification by magnetic resonance imaging: proton density fat fraction in polycystic ovary syndrome

A comparison of cardiovascular risk indices in patients with polycystic ovary syndrome with and without coexisting nonalcoholic fatty liver disease

Quantitative Assessment of Intrahepatic Fat Content in Children and Adolescents with Non-Alcoholic Fatty Liver Disease

A meta-analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver disease

A Prospective Comparison of Three Ultrasound-Based Techniques in Quantitative Diagnosis of Hepatic Steatosis in NAFLD.

The Clinical Characteristics and Etiological Study of Nonalcoholic Fatty Liver Disease in Chinese Women with Pcos

Prevalence and characteristics of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome

Ultrasound characteristic and its correlation with endocrine profile in obese polycystic ovary syndrome patients

[Effect of Obesity on Nonalcoholic Fatty Liver Disease in Chinese Women with Polycystic Ovary Syndrome].

Circulating Osteopontin and Its Association with Liver Fat Content in Non-Obese Women with Polycystic Ovary Syndrome: a Case Control Study

High-free Androgen Index is Associated with Increased Risk of Non-Alcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome, Independent of Obesity and Insulin Resistance

The correlation between polycystic ovary syndrome and non-alcoholic fatty liver disease

Non‐alcoholic Fatty Liver Disease in Premenopausal Women with Polycystic Ovary Syndrome: A Systematic Review and Meta‐analysis

[Clinical value of multiparameteric quantitative ultrasound for assessing high-risk steatohepatitis]

Nonalcoholic fatty liver disease risk in polycystic ovary syndrome patients

Evaluation of hepatic stiffness by ultrasonic elastography quantitative analysis: preliminary experience